Early detection of hepatocellular carcinoma in patients with chronic type B hepatitis-Reference-Cited by-同舟云学术

Early detection of hepatocellular carcinoma in patients with chronic type B hepatitis

Published:1986-02 Issue:2 Volume:90 Page:263-267
ISSN:0016-5085
Container-title:Gastroenterology
language:en
Short-container-title:Gastroenterology

Author:

Liaw Yun-Fan,Tai Dar-In,Chu Chia-Ming,Lin Deng-Yn,Sheen I-Shyan,Chen Tong-Jong,Pao Chia C.

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference23 articles.

1. Hepatitis B antigen and α-fetoprotein in hepatoma in Taiwan;Liaw;J Formosan Med Assoc,1973

2. Seroconversion from hepatitis B e antigen to anti-HBe in chronic hepatitis B virus infection;Realdi;Gastroenterology,1980

3. Hepatocellular carcinoma and hepatitis B virus: a prospective study of 22,707 men in Taiwan;Beasley;Lancet,1981

4. HBeAg/anti-HBe system and development of primary hepatocellular carcinoma in patients with HBsAg-positive liver cirrhosis;Musca;Hepatogastroenterology,1983

5. Age-specific prevalence and significance of hepatitis B e antigen and antibody in chronic hepatitis B virus infection in Taiwan: a comparison among asymptomatic carriers, chronic hepatitis, liver cirrhosis and hepatocellular carcinoma;Liaw;J Med Virol,1984

Cited by 291 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Treat All versus targeted strategies to select HBV-infected people for antiviral therapy in The Gambia, west Africa: a cost-effectiveness analysis;The Lancet Global Health;2024-01

2. Smoking as a Risk Factor for Very Late Recurrence in Surgically Resected Early-Stage Primary Hepatocellular Carcinoma;Clinical Medicine Insights: Oncology;2024-01

3. Above-Standard Survival of Hepatocellular Carcinoma as the Final Outcome of Comprehensive Hepatology Care Programs in a Remote HCV-Endemic Area;Viruses;2023-03-19

4. Short Half-Life of Des-γ-Carboxy Prothrombin Is a Superior Factor for Early Prediction of Outcomes of Hepatocellular Carcinoma Treated with Radiofrequency Ablation;Diagnostics;2023-02-12

5. Cost Effectiveness of Implementing a Universal Birth Hepatitis B Vaccination Program in Ontario;PharmacoEconomics;2023-01-28